Akbaba, M., Gökmen, G. G., Kışla, D., & Nalbantsoy, A. (2023). In vivo investigation of supportive immunotherapeutic combination of
Bifidobacterium infantis 35624 and doxorubicin in murine breast cancer.
Probiotics and Antimicrobial Proteins, 15(4), 880–888.
https://doi.org/10.1007/s12602-021-09899-w
Baneshi, M., Dadfarnia, S., Haji Shabani, A. M., Sabbagh, S. K., Haghgoo, S., & Bardania, H. (2019). A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
International Journal of Pharmaceutics, 564, 145–152.
https://doi.org/10.1016/j.ijpharm.2019.04.025
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA: A Cancer Journal for Clinicians, 68(6), 394–424.
https://doi.org/10.3322/caac.21492
DeRosa, M. C., Lin, A., Mallikaratchy, P., McConnell, E. M., McKeague, M., Patel, R., & Shigdar, S. (2023). In vitro selection of aptamers and their applications.
Nature Reviews Methods Primers, 3, 55.
https://doi.org/10.1038/s43586-023-00247-6
Eralp, T. N., Sevinc, A., & Mansuroglu, B. (2024). Combination therapy application of abemaciclib with doxorubicin in triple-negative breast cancer cell line MDA-MB-231: Synergistic effect of doxorubicin and abemaciclib.
Cellular and Molecular Biology, 70(2), 169–177.
https://doi.org/10.14715/cmb/2024.70.2.24
Fan, R., Tao, X., Zhai, X., Zhu, Y., Li, Y., Chen, Y., Dong, D., Yang, S., & Lv, L. (2023). Application of aptamer-drug delivery system in the therapy of breast cancer.
Biomedicine & Pharmacotherapy, 161, 114444.
https://doi.org/10.1016/j.biopha.2023.114444
Hazeri, Y., Samie, A., Ramezani, M., Alibolandi, M., Yaghoobi, E., Dehghani, S., Zolfaghari, R., Khatami, F., Zavvar, T. S., Alinezhad Nameghi, M., Abnous, K., & Taghdisi, S. M. (2022). Dual-targeted delivery of doxorubicin by mesoporous silica nanoparticle coated with AS1411 aptamer and RGDK-R peptide to breast cancer in vitro and in vivo.
Journal of Drug Delivery Science and Technology, 71, 103285.
https://doi.org/10.1016/j.jddst.2022.103285
Iranpour, S., Bahrami, A. R., Saljooghi, A. S., & Matin, M. M. (2021a). Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy.
Coordination Chemistry Reviews, 442, 213949.
https://doi.org/10.1016/j.ccr.2021.213949
Iranpour, S., Bahrami, A. R., Nekooei, S., Saljooghi, A. S., & Matin, M. M. (2021b). Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.
Journal of Nanobiotechnology, 19, 314.
https://doi.org/10.1186/s12951-021-01056-3
Jabłońska-Trypuć, A., Świderski, G., Krętowski, R., & Lewandowski, W. (2017). Newly synthesized doxorubicin complexes with selected metals—Synthesis, structure and anti-breast cancer activity.
Molecules, 22(7), 1106.
https://doi.org/10.3390/molecules22071106
Javid, A., Ahmadian, S., Saboury, A. A., Kalantar, S. M., & Rezaei-Zarchi, S. (2013). Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: Synthesis and anticancer effect against human ovarian cancer cells.
Chemical Biology & Drug Design, 82(3), 296–306.
https://doi.org/10.1111/cbdd.12145
Rus, I., Tertiș, M., Paşcalău, V., Pavel, C., Melean, B., Suciu, M., Moldovan, C., Topală, T., Popa, C., Săndulescu, R., & Cristea, C. (2021). Simple and fast analytical method for the evaluation of the encapsulation and release profile of doxorubicin from drug delivery systems.
)